The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Joint cell-line and patient modeling of drug sensitivity reveals novel molecular biomarkers for targeted and conventional chemotherapy.
Charles Ferte
No relevant relationships to disclose
Elias Chaibub Neto
No relevant relationships to disclose
Frederic Commo
No relevant relationships to disclose
Olga Nikolova
No relevant relationships to disclose
in Sock Jang
No relevant relationships to disclose
Mehmet Gonen
No relevant relationships to disclose
Ludovic Lacroix
No relevant relationships to disclose
Valerie Koubi-Pick
No relevant relationships to disclose
Eric Angevin
No relevant relationships to disclose
Benjamin Besse
No relevant relationships to disclose
Michel Ducreux
No relevant relationships to disclose
Antoine Hollebecque
No relevant relationships to disclose
Christophe Massard
No relevant relationships to disclose
Adam Margolin
No relevant relationships to disclose
Stephen Henry Friend
No relevant relationships to disclose
Fabrice Andre
No relevant relationships to disclose
Jean-Charles Soria
No relevant relationships to disclose
Justin Guinney
No relevant relationships to disclose